Expanding Access to Precision Cancer Care with the Precision Cancer Consortium CGP Implementation Guide
- Advancing Access to Precision Oncology: The Precision Cancer Consortium developed The Pathway to Precision Cancer Care, a strategic and operational guide to help health systems embed comprehensive genomic profiling (CGP) into routine cancer care and expand patient access globally
- The Impact of Limited CGP Capacity: Without coordinated action, patients miss opportunities for accurate diagnosis, targeted therapies, and clinical trials; costs rise due to inefficiencies; results may be delayed or misinterpreted; and patients and families lack information for shared decision-making
- Clinical & Economic Value at Risk: Limited access to CGP constrains patient outcomes and prevents health systems from realizing the wider economic value that precision oncology can deliver beyond healthcare
- Practical, Adaptable Solutions: The freely available, interactive guide provides actionable steps, tools, and real world examples to help health systems initiate, scale, and strengthen CGP programs. This session highlights how it is being used to improve access to optimal treatments